A detailed history of Avoro Capital Advisors LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Avoro Capital Advisors LLC holds 2,858,888 shares of UTHR stock, worth $1.06 Billion. This represents 15.42% of its overall portfolio holdings.

Number of Shares
2,858,888
Previous 2,858,888 -0.0%
Holding current value
$1.06 Billion
Previous $911 Million 12.49%
% of portfolio
15.42%
Previous 12.43%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$214.88 - $256.94 $1.37 Million - $1.64 Million
6,388 Added 0.22%
2,858,888 $629 Million
Q3 2023

Nov 14, 2023

SELL
$211.82 - $248.24 $12.2 Million - $14.3 Million
-57,499 Reduced 1.98%
2,852,500 $644 Million
Q2 2023

Aug 14, 2023

BUY
$205.19 - $232.99 $8.21 Million - $9.32 Million
39,999 Added 1.39%
2,909,999 $642 Million
Q1 2023

May 15, 2023

BUY
$212.99 - $276.17 $1.06 Million - $1.38 Million
5,000 Added 0.17%
2,870,000 $643 Million
Q4 2022

Feb 14, 2023

SELL
$205.95 - $280.43 $12.7 Million - $17.2 Million
-61,500 Reduced 2.1%
2,865,000 $797 Million
Q3 2022

Nov 14, 2022

SELL
$203.3 - $244.17 $8.84 Million - $10.6 Million
-43,500 Reduced 1.46%
2,926,500 $613 Million
Q2 2022

Aug 15, 2022

SELL
$174.81 - $241.14 $10.5 Million - $14.5 Million
-60,000 Reduced 1.98%
2,970,000 $700 Million
Q1 2022

May 16, 2022

SELL
$166.16 - $213.96 $830,800 - $1.07 Million
-5,000 Reduced 0.16%
3,030,000 $544 Million
Q4 2021

Feb 14, 2022

BUY
$184.32 - $216.08 $6.45 Million - $7.56 Million
35,000 Added 1.17%
3,035,000 $656 Million
Q1 2021

May 17, 2021

BUY
$153.94 - $174.85 $23.1 Million - $26.2 Million
150,000 Added 5.26%
3,000,000 $502 Million
Q4 2020

Feb 16, 2021

BUY
$101.87 - $151.79 $290 Million - $433 Million
2,850,000 New
2,850,000 $433 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.8B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Avoro Capital Advisors LLC Portfolio

Follow Avoro Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avoro Capital Advisors LLC with notifications on news.